DNA damage resulting in multiple broken chromosomes (Photo credit: Wikipedia)
New research in The FASEB Journal suggests that white blood cells exposed to UVA light in agar, to induce DNA damage, can predict if one has or is at risk for cancer
A new research report published in the October 2014 issue of The FASEB Journal may make the early detection of cancer as easy as a simple blood test. This test, called the “lymphocyte genome sensitivity” (LGS) test, could not only detect some cancers earlier than ever before, but it may eliminate the need for some types of biopsies, as well as identify those more likely to develop cancer in the future.
“The test could allow earlier cancer detection, so helping to save peoples’ lives,” said Diana Anderson, a researcher involved in the work from the School of Life Sciences at the University of Bradford in West Yorkshire, United Kingdom.
To develop this test, Anderson and colleagues took blood samples from a group of people that included healthy individuals, cancer patients and people believed to be at a higher risk than normal to develop cancer. White blood cells (lymphocytes) in these samples were examined in a Comet test, by embedding the cells in a jelly-like substance, called agar, on a microscope slide. In this test, damage to the genetic material (DNA) of the cells was caused by treatment with ultraviolet (UVA) light. This damage was observed in the form of DNA pieces being pulled within the agar in an electric field toward the positive end of the field. This caused a comet-like tail, and the longer the tail the more DNA damage. Different thicknesses of the agar were applied to the slides. In healthy people, as different thicknesses were added, DNA-damaged tail responses returned to normal levels. In cancer patients, DNA-damaged tail responses remained high and in those people who might develop pre-cancerous diseases, tail responses were in between. This means that people with cancer have DNA which is more easily damaged by UVA than do other people, so the test shows the sensitivity to damage of all the genome in a cell. The LGS test has been used to examine blood samples from cancer patients with melanoma, colon cancer and lung cancer, and all gave the same outcomes.
The Latest on: Cancer blood test
Freenome draws $160M to support its 'multiomics' cancer blood test programs - FierceBiotech
July 24, 2019 - Freenome draws $160M to support its 'multiomics' cancer blood test programs FierceBiotechWith $160 million in new funding, Freenome looks to commercialize its blood test to detect colorectal cancer TechCrunchFreenome Secures $160 Million to Advance Cancer Detection Blood Test BioSpaceFreenome Snags $160M to Boost Blood Test for Early Cancer Detection XconomyFreenome raises $160m as it readies early detection cancer tests Financial TimesView full coverage on Google NewsBreast cancer: Blood test may predict relapse - Medical News Today
July 10, 2019 - Breast cancer: Blood test may predict relapse Medical News TodayNew research introduces an innovative blood test that may predict the chances of breast cancer recurring by measuring a person's antitumor response.
New Blood Test May Predict Potential Breast Cancer Relapse - Specialty Pharmacy Times
July 23, 2019 - New Blood Test May Predict Potential Breast Cancer Relapse Specialty Pharmacy TimesA blood test might one day predict whether a newly diagnosed patient with breast cancer will likely relapse years later, a City of Hope study suggests. According ...
July 25, 2019 - Kaiser Permanente, American Cancer Society join blood test startup's $160M funding round Becker's Hospital ReviewSouth San Francisco-based biotech company Freenome announced the close of a $160 million funding round, with participation from Kaiser Permanente ...
Blood Test May Be Able To Predict Breast Cancer Relapse - Forbes
July 12, 2019 - Blood Test May Be Able To Predict Breast Cancer Relapse ForbesA new blood test using immune markers may be able to predict relapse of breast cancer at the point where patients are diagnosed.
Blood test may predict risk of recurrence for breast cancer patients - Medical Xpress
July 8, 2019 - Blood test may predict risk of recurrence for breast cancer patients Medical XpressA special blood test may one day predict if a newly diagnosed breast cancer patient will likely relapse years later, a City of Hope study suggests.
Readers Write: New blood tests developed for early cancer detection - The Island Now
July 1, 2019 - Readers Write: New blood tests developed for early cancer detection The Island NowCEO Helmy Eltoukhy, Guardant Health co-founder, said at the recent American Society of Clinical Oncology meeting “scientists aren't far from creating blood ...
'World's most accurate blood test' for prostate cancer launched in UK - PharmaTimes
July 18, 2019 - 'World's most accurate blood test' for prostate cancer launched in UK PharmaTimesMDNA Life Sciences has announced that its Mitomic Prostate Test (MPT) – the world's most accurate blood test to determine whether a man does or does not ...July 25, 2019 - Biocept changing the way physicians examine blood work for their cancer patients Proactive Investors USA & CanadaBiocept Inc (NASDAQ:BIOC) - The San Diego-based company has developed a patented liquid biopsy technology called Target Selector that detects and ...
‘Maybe you’re just someone with blood in their urine’ - The Washington Post
July 27, 2019 - ‘Maybe you’re just someone with blood in their urine’ The Washington PostA 45-year-old Idaho woman's search for the elusive cause of her bleeding involved numerous tests. A belated scan revealed the terrifying reason.
via Google News
The Latest on: Cancer blood test
- This cancer startup drew lessons from a refugee campon July 28, 2019 at 7:43 am
Cancer cell lines in the lab are different from a tumour in the body. Immune cells, connective tissues and blood vessels around a tumour play a role in its growth. Majumder’s idea was to recreate that ... […]
- 10 Biggest Cancer-Fighting Stockson July 28, 2019 at 3:35 am
Liquid biopsies (blood tests that detect cancer by finding DNA that has broken off from tumor cells) is likely to become increasingly important in the diagnosis of cancer. Cancer treatments ... […]
- Prostate cancer blood test heralded as 'the most accurate ever' could cut invasive biopsies by a thirdon July 27, 2019 at 10:00 am
A blood test heralded as ‘the most accurate ever’ way to detect prostate cancer could spare thousands of men suspected of having the disease from the risks and discomfort of invasive biopsies. The ... […]
- ‘Maybe you’re just someone with blood in their urine’on July 27, 2019 at 9:00 am
(Blood in the urine and fatigue are common symptoms ... for genetic mutations that could guide future treatment, were clean. And her lab tests were normal. Because her cancer is rare, Archie suggested ... […]
- Kaiser Permanente, American Cancer Society join blood test startup's $160M funding roundon July 25, 2019 at 11:31 am
South San Francisco-based biotech company Freenome announced the close of a $160 million funding round, with participation from Kaiser Permanente Ventures, the American Cancer Society's BrightEdge ... […]
- With $160 million in new funding, Freenome looks to commercialize its blood test to detect colorectal canceron July 24, 2019 at 6:22 pm
One of the major problems that technology companies working to find a cure for cancer need to solve is finding a safe, minimally invasive way to detect cancers early. Almost all cancer screening ... […]
- Freenome nabs $160M to advance blood-based colorectal cancer teston July 24, 2019 at 2:42 pm
Investors have poured boatloads of cash into liquid biopsy companies promising that their technology is the solution for non-invasive screening of early-stage cancer. In the latest mega funding ... […]
- Freenome Closes $160 Million Series B Financing to Advance Its Multiomics Blood Testing Platform for Early Cancer Detectionon July 24, 2019 at 6:31 am
Freenome will use the proceeds to further the development of its early cancer detection blood test powered by its platform. The Company plans to conduct a pivotal validation study and submit to the ... […]
- Liquid biopsy chip detects tumor cells in 100 percent of blood samples from breast cancer patientson July 24, 2019 at 6:25 am
They found that the lysing process has no effect on the CTCs. Tests of the chip using blood spiked with a known number of cancer cells tagged with fluorescent dye showed that it has a high ... […]
- Freenome Snags $160M to Boost Blood Test for Early Cancer Detectionon July 24, 2019 at 6:09 am
Freenome, one of the rivals racing to detect the earliest signs of cancer through blood tests, announced Wednesday it has raised $160 million in a Series B funding round. The money boosts Freenome ... […]
via Bing News
